The sacroiliac joint is a common source of chronic lower back pain and a novel RFA-based approach to sacroiliac joint denervation may provide intermediate-term pain relief and functional benefit ...
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the Tenon Medical Third Quarter 2024 ...
Needham analyst David Saxon reiterated a Buy rating on SI-Bone (SIBN – Research Report) today and set a price target of $19.00. David ...
Analyst Drew Ranieri from Morgan Stanley maintained a Buy rating on SI-Bone (SIBN – Research Report) and keeping the price target at ...
Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its third-quarter 2024 financial results, ...
US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...
Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~~ Published Interim Analysis from MAINSAIL Study; Post-Market ...
Injuries and osteoarthritis of the knee are common. Fortunately, there are many ways to prevent and treat knee pain.